arecoline has been researched along with tram 34 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsing, CH; Huang, YM; Liao, YK; So, EC; Wu, SN | 1 |
1 other study(ies) available for arecoline and tram 34
| Article | Year |
|---|---|
Arecoline inhibits intermediate-conductance calcium-activated potassium channels in human glioblastoma cell lines.
Topics: Arecoline; Benzimidazoles; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Kinetics; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Membrane Potentials; Potassium Channel Blockers; Primary Cell Culture; Pyrazoles | 2015 |